| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.51 | 1e-14 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-10 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.18 | 1e-05 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.18 | 1e-05 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.19 | 1e-05 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-05 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.17 | 4e-05 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.23 | 6e-05 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.31 | 8e-05 |